Over the last several years, medical cannabis oils have helped those suffering from severe epilepsy to live normal lives throughout the nation. Now, Idaho’s state senate is working to pass its own bill to bring life-improving medication to its citizens. However, the committee still seems undecided as to whether doing so will help those in need or merely open the door for recreational marijuana in the future.
Since last month, the Idaho state senate bill, 1146aa, has been on a rollercoaster, amended and read before representatives three times. At the initial vote back on March 30th, the senate was deadlocked, voting 8 to 8. As of April 2, the bill has once again been revived by a 22 to 12 majority, this time to be read and voted on in full.
This recount came after three of the original committee members decided to change their vote after hearing nine hours of testimony from physicians as well as the parents of the children suffering. Now, the bill is set to be read before the governor and a full house on April 6.
While it is uncommon for a bill to be revived, the recent emotional testimony has swayed the committee. The bill has become known as Alexis’ Law, named after Alexis Carey, a 10 year old suffering from epileptic seizures as a part of Dravet Syndrome.
Idahoans suffering from this rare form of epilepsy are eager to change the court’s mind, stating that the cannabis oil in question is entirely medical and absent of THC. The ‘CBD only’ bill still scares opponents of the measure – saying it will only open the doors for more medical options and recreational use.
Photo Credit: Yahoo